Contact Us
Drug Search Results
More Filters [+]

Topiroxostat

Alternative Names: topiroxostat
Latest Update: 2024-04-24
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: XO Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India | Japan

Approved Indications: None

Known Adverse Events: None

Company: Fuji Yakuhin
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Topiroxostat

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Gout

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CTR20202265

P1

Recruiting

Gout

None

Recent News Events

Date

Type

Title

04/24/2024

PubMed

 Evaluation of the inhibitory effects of antigout drugs on human carboxylesterases in vitro.

03/26/2024

PubMed

 Multicenter randomized controlled trial of intensive uric acid lowering therapy for CKD patients with hyperuricemia: TARGET-UA.

03/19/2024

PubMed

 Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.

09/15/2021

News Article

 Hyperuricemia (Metabolic Disorder) Drugs In Development, 2021 Pipeline Landscape Report - ResearchAndMarkets.com

08/30/2021

News Article

 Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad, a Treatment for Hyperuricemia and Gout, in Five ASEAN Countries

05/10/2021

News Article

 Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop Dotinurad in North America and Europe

02/24/2020

News Article

 Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad, a Treatment for Hyperuricemia and Gout, in China

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions